Direct assembly framework for osseointegrated implant prosthesis

A framework design for an osseointegrated implant fixed or detachable prosthesis prevents stress from being incorporated into the bone-fixture-prosthesis system. The framework consists of components that are joined by cement intraorally and allows adaptation of the framework to abutments within 5 microns. Components and biomechanics of the direct assembly framework are discussed. Advantages include a simplified laboratory and clinical technique. A treatment procedure of four appointments is necessary, including impressions, jaw-relation records, esthetic trial fitting, and framework assembly and insertion.     

Co-ordinated treatment of secondary cleft deformities

Secondary cleft deformities result from the cumulative effects of functional and morphological abnormalities. Treatment choices should be based on a comprehensive plan which is designed to minimize treatment time and iatrogenic effects and which is based on sound physical and psychosocial objectives. Conventional orthodontic and orthognathic surgical principles can be modified and applied to a variety of facial cleft problems. Direct surgical correction of secondary deformities instead of prosthetic or orthodontic compensation expands treatment possibilities and optimizes treatment results.     

Documenting medication use in adult dental patients: 1987-1991.

The authors surveyed 5,002 dental outpatients to determine the prevalence and patterns of drug use. They found that drug use increased significantly with age and that a significant number of patients took medications that had potential for adverse dental effects. Thus, dentists should be aware of patient medications and the effects those drugs have on dental treatment.     

Visual and profilometric wear measurements.

Wear of composites can be estimated by the degree of marginal discrepancy between the prepared cavity wall and the occlusal margins of composites. Such evaluations are done on casts by comparing and rating the marginal discrepancy with those on standard casts. We analyzed the reliability of this technique on metal and stone specimens. These specimens contained grooves of different width and depth. For the visual comparison we used stone casts of machined standards of known groove depth. We measured the depths of the metal specimens with a profilometer and made stone casts of these original specimens. Using the stone casts of the standards, five dentists estimated the unknown groove depths on the remaining stone casts. These estimates were done under standardized conditions and repeated by each dentist on five different occasions. The results showed that visual depth evaluations of die stone specimens underestimated the depths when compared with the values measured with a profilometer on the original metal models. One investigator gave significantly different (p less than 0.05) groove depth estimates at different occasions.     

Prostaglandin E2 and interleukin-1 levels in smokeless tobacco-induced oral mucosal lesions

Inflammatory mediators released as a result of smokeless tobacco (ST)-induced irritation may play a role in the development of oral mucosal lesions at habitual tobacco placement sites in ST users. The present study examined levels of interleukin-1 (IL-1) and prostaglandin E2 (PGE2) in ST-induced mucosal lesions and compared these to mediator levels in clinically normal mucosa. Soft tissue biopsies were obtained from white mucosal lesions at habitual placement sites and normal alveolar mucosal tissue at non-placement sites in 18 ST users. Fifteen non-tobacco using subjects also provided normal alveolar mucosal biopsies. IL-1 and PGE2 were recovered from the specimens, and mediator levels were determined by enzyme immunoassay. Prostaglandin E2 levels (pg/mg) were lower in both regions in the ST subjects, but values did not vary significantly between the regions with 2.77±0.72 and 2.86±0.99 at placement and non-placement sites, respectively, in ST users and 7.31±3.84 in non-tobacco users. Both IL-1α and IL-lβ (pg/mg) were significantly (p < 0.0I) elevated in ST lesions (IL-lã=25.56±4.00; IL-1β=7.76±1.68) compared to either non-placement sites in ST users (IL-lα=14.64±2.65; IL-lβ=1.63±0.72) or non-tobacco users (IL-lα=12.84±2.60; IL-lβ=2.04±0.75). In view of IL-l's role in keratinocyte proliferation and its inflammatory effects, this cytokine may contribute to mucosal and gingival alterations observed in ST users.     

The effectiveness of the Titan-S sonic scaler versus curettes in the removal of subgingival calculus. A human surgical evaluation

This study evaluated clinically the effectiveness of hand versus sonic subgingival scaling and root planing in the removal of calculus by visually examining the root surface at the time of periodontal flap surgery. Consideration was given to the method of instrumentation, probing depth, number of roots, and type of tooth surface. Eleven patients with moderate to advanced periodontal disease were evaluated. Four subjects were scaled and root planed with the Titan-S only, four with curettes only, and three with the Titan-S + curettes. At reevaluation 3 to 6 weeks after scaling and root planing, the decision to perform periodontal flap surgery was made based upon probing depth, bleeding upon probing, previous access to the root surface, furcation involvement, and the patient's level of oral hygiene. A full thickness mucoperiosteal flap was elevated to gain access to the root surface and measure the distance from the cementoenamel junction to the residual calculus. A total of 690 surfaces were evaluated surgically. The percentage of surfaces with residual calculus for each method of instrumentation was: Titan-S only (31.9%), curettes only (26.8%), and Titan-S + curettes (16.9%). Overall, 15.7% of the surfaces probing 0 to 3 mm, 29.3% of the surfaces probing 4 to 5 mm, and 44.4% of the surfaces probing 6 to 12 mm had residual calculus.(ABSTRACT TRUNCATED AT 250 WORDS)     

A prospective clinical study of bone augmentation techniques at immediate implants

The efficacy of combinations of membranes and autogenous bone grafts at immediate implants were compared in a prospective study. Sixty-two consecutively treated patients each received an immediate implant for a single tooth replacement at a maxillary anterior or premolar site. Dimensions of the peri-implant defect at the implant collar were measured as follows: vertical defect height (VDH), horizontal defect depth (HDD) and horizontal defect width (HDW). Each implant randomly received one of five augmentation treatments and were submerged with connective tissue grafts: Group 1 (n=12)--expanded polytetrafluoroethylene membrane only, Group 2 (n=11)--resorbable polylactide/polyglycolide copolymer membrane only, Group 3 (n=13)--resorbable membrane and autogenous bone graft; Group 4 (n=14)--autogenous bone graft only, and Group 5 (n=12)--no membrane and no bone graft control. At re-entry, all groups showed significant reduction in VDH, HDD and HDW. Comparisons between groups showed no significant differences for VDH (mean 75.4%) and HDD (mean 77%) reduction. Significant differences were observed between groups for HDW reduction (range, 34.1-67.3%), with membrane-treated Groups 1, 2 and 3 showing the greatest reduction. In the presence of dehiscence defects of the labial plate, HDW reduction of 66.6% was achieved with membrane use compared with 37.7% without membranes. Over 50% more labial plate resorption occurred in the presence of a dehiscence defect irrespective of the augmentation treatment used. The results indicate that VDH and HDD reduction at defects adjacent to immediate implants may be achieved without the use of membranes and/or bone grafts.